A computationally designed water-soluble variant of a G-protein-coupled receptor: the human mu opioid receptor.

PubWeight™: 0.88‹?›

🔗 View Article (PMC 3682944)

Published in PLoS One on June 14, 2013

Authors

Jose Manuel Perez-Aguilar1, Jin Xi, Felipe Matsunaga, Xu Cui, Bernard Selling, Jeffery G Saven, Renyu Liu

Author Affiliations

1: Department of Chemistry, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America.

Articles cited by this

Basic local alignment search tool. J Mol Biol (1990) 659.07

Comparative protein modelling by satisfaction of spatial restraints. J Mol Biol (1993) 64.61

Amino acid substitution matrices from protein blocks. Proc Natl Acad Sci U S A (1992) 61.33

MolProbity: all-atom contacts and structure validation for proteins and nucleic acids. Nucleic Acids Res (2007) 37.31

High-resolution crystal structure of an engineered human beta2-adrenergic G protein-coupled receptor. Science (2007) 20.32

Knowledge-based protein secondary structure assignment. Proteins (1995) 14.08

Chemistry of ion coordination and hydration revealed by a K+ channel-Fab complex at 2.0 A resolution. Nature (2001) 13.76

The 2.6 angstrom crystal structure of a human A2A adenosine receptor bound to an antagonist. Science (2008) 11.74

The G-protein-coupled receptors in the human genome form five main families. Phylogenetic analysis, paralogon groups, and fingerprints. Mol Pharmacol (2003) 9.99

Infrastructure for the life sciences: design and implementation of the UniProt website. BMC Bioinformatics (2009) 8.87

Structure and gating mechanism of the acetylcholine receptor pore. Nature (2003) 8.30

Bayesian statistical analysis of protein side-chain rotamer preferences. Protein Sci (1997) 7.92

The retinal conformation and its environment in rhodopsin in light of a new 2.2 A crystal structure. J Mol Biol (2004) 7.38

Crystal structure of the µ-opioid receptor bound to a morphinan antagonist. Nature (2012) 6.18

A specific cholesterol binding site is established by the 2.8 A structure of the human beta2-adrenergic receptor. Structure (2008) 6.01

Structure of the human κ-opioid receptor in complex with JDTic. Nature (2012) 5.18

Conformational thermostabilization of the beta1-adrenergic receptor in a detergent-resistant form. Proc Natl Acad Sci U S A (2008) 3.77

Structure of the δ-opioid receptor bound to naltrindole. Nature (2012) 3.69

Structural basis for allosteric regulation of GPCRs by sodium ions. Science (2012) 3.40

Cholesterol interactions with phospholipids in membranes. Prog Lipid Res (2002) 3.34

Opioid prescriptions soar: increase in legitimate use as well as abuse. JAMA (2007) 3.13

X-ray structures of general anaesthetics bound to a pentameric ligand-gated ion channel. Nature (2011) 3.00

Structure of the nociceptin/orphanin FQ receptor in complex with a peptide mimetic. Nature (2012) 2.96

Therapeutic opioids: a ten-year perspective on the complexities and complications of the escalating use, abuse, and nonmedical use of opioids. Pain Physician (2008) 2.90

Characteristics of opioid prescriptions in 2009. JAMA (2011) 2.80

Hydrophobic organization of membrane proteins. Science (1989) 2.74

Clinical pharmacology of opioids for pain. Clin J Pain (2002) 1.85

Statistical theory for protein combinatorial libraries. Packing interactions, backbone flexibility, and the sequence variability of a main-chain structure. J Mol Biol (2001) 1.42

Architecture of helix bundle membrane proteins: an analysis of cytochrome c oxidase from bovine mitochondria. Protein Sci (1997) 1.38

Computational design of water-soluble analogues of the potassium channel KcsA. Proc Natl Acad Sci U S A (2004) 1.31

Recent progress in the structure determination of GPCRs, a membrane protein family with high potential as pharmaceutical targets. Methods Mol Biol (2010) 1.27

Theoretical and computational protein design. Annu Rev Phys Chem (2011) 1.26

Statistical theory of combinatorial libraries of folding proteins: energetic discrimination of a target structure. J Mol Biol (2000) 1.21

A fluorescent ligand-binding alternative using Tag-lite® technology. J Biomol Screen (2010) 1.13

Overexpression and role of the ATPase and putative DNA helicase RuvB-like 2 in human hepatocellular carcinoma. Hepatology (2007) 1.08

A knowledge-based scale for the analysis and prediction of buried and exposed faces of transmembrane domain proteins. Bioinformatics (2004) 1.02

Molecular docking reveals a novel binding site model for fentanyl at the mu-opioid receptor. J Med Chem (2000) 1.02

Why are polar residues within the membrane core evolutionary conserved? Proteins (2010) 1.02

NMR studies of a channel protein without membranes: structure and dynamics of water-solubilized KcsA. Proc Natl Acad Sci U S A (2008) 1.00

Bacterial expression of functional, biotinylated peripheral cannabinoid receptor CB2. Protein Expr Purif (2006) 0.98

Computational design of membrane proteins. Structure (2012) 0.95

NMR structure and dynamics of a designed water-soluble transmembrane domain of nicotinic acetylcholine receptor. Biochim Biophys Acta (2011) 0.93

The role of cholesterol on the activity and stability of neurotensin receptor 1. Biochim Biophys Acta (2012) 0.91

G protein-coupled receptor structural motifs: relevance to the opioid receptors. Curr Top Med Chem (2005) 0.91

An automated application for deconvolution of circular dichroism spectra of small peptides. Anal Biochem (2007) 0.87

Expression of delta, kappa and mu human opioid receptors in Escherichia coli and reconstitution of the high-affinity state for agonist with heterotrimeric G proteins. Eur J Biochem (1999) 0.87

Solubilization, purification, and mass spectrometry analysis of the human mu-opioid receptor expressed in Pichia pastoris. Protein Expr Purif (2005) 0.86

Molecular Dynamics Simulation of WSK-3, a Computationally Designed, Water-Soluble Variant of the Integral Membrane Protein KcsA. Biophys J (2005) 0.83

Mutation of human mu opioid receptor extracellular "disulfide cysteine" residues alters ligand binding but does not prevent receptor targeting to the cell plasma membrane. Brain Res Mol Brain Res (1999) 0.82

The full-length mu-opioid receptor: a conformational study by circular dichroism in trifluoroethanol and membrane-mimetic environments. J Membr Biol (2008) 0.80

Human μ Opioid Receptor Models with Evaluation of the Accuracy Using the Crystal Structure of the Murine μ Opioid Receptor. J Anesth Clin Res (2012) 0.79

Beyond the detergent effect: a binding site for sodium dodecyl sulfate (SDS) in mammalian apoferritin. Acta Crystallogr D Biol Crystallogr (2012) 0.79

The N-terminal end truncated mu-opioid receptor: from expression to circular dichroism analysis. Appl Biochem Biotechnol (2009) 0.78

Articles by these authors

Motor-sensory recalibration leads to an illusory reversal of action and sensation. Neuron (2006) 2.38

Airway trauma in a high patient volume academic cardiac electrophysiology laboratory center. Anesth Analg (2012) 2.06

CYP3A4 induction by drugs: correlation between a pregnane X receptor reporter gene assay and CYP3A4 expression in human hepatocytes. Drug Metab Dispos (2002) 1.94

Angiopoietin1/Tie2 and VEGF/Flk1 induced by MSC treatment amplifies angiogenesis and vascular stabilization after stroke. J Cereb Blood Flow Metab (2007) 1.89

Outcomes of anterior and posterior instrumentation under different surgical procedures for treating thoracic and lumbar spinal tuberculosis in adults. Int Orthop (2011) 1.61

Computational design and characterization of a monomeric helical dinuclear metalloprotein. J Mol Biol (2003) 1.60

Computational de novo design and characterization of a four-helix bundle protein that selectively binds a nonbiological cofactor. J Am Chem Soc (2005) 1.52

Flexible and transparent MoS2 field-effect transistors on hexagonal boron nitride-graphene heterostructures. ACS Nano (2013) 1.42

Solution-processed graphene/MnO2 nanostructured textiles for high-performance electrochemical capacitors. Nano Lett (2011) 1.41

A unitary anesthetic binding site at high resolution. J Biol Chem (2009) 1.34

White matter damage and the effect of matrix metalloproteinases in type 2 diabetic mice after stroke. Stroke (2010) 1.33

Computational design of water-soluble analogues of the potassium channel KcsA. Proc Natl Acad Sci U S A (2004) 1.31

Identification of a fluorescent general anesthetic, 1-aminoanthracene. Proc Natl Acad Sci U S A (2009) 1.29

Niaspan increases angiogenesis and improves functional recovery after stroke. Ann Neurol (2007) 1.27

Theoretical and computational protein design. Annu Rev Phys Chem (2011) 1.26

Ultrafast folding of a computationally designed Trp-cage mutant: Trp2-cage. J Phys Chem B (2006) 1.26

Case report: Anti-N-methyl-D-aspartate receptor encephalitis and its anesthetic implications. Anesth Analg (2011) 1.25

Bone marrow stromal cells enhance inter- and intracortical axonal connections after ischemic stroke in adult rats. J Cereb Blood Flow Metab (2010) 1.24

Computational design of a protein crystal. Proc Natl Acad Sci U S A (2012) 1.23

Statistical and molecular dynamics studies of buried waters in globular proteins. Proteins (2005) 1.23

Evolutionary constraints on structural similarity in orthologs and paralogs. Protein Sci (2009) 1.23

m-Azipropofol (AziPm) a photoactive analogue of the intravenous general anesthetic propofol. J Med Chem (2010) 1.21

Computational protein design to reengineer stromal cell-derived factor-1α generates an effective and translatable angiogenic polypeptide analog. Circulation (2011) 1.20

De novo design of a redox-active minimal rubredoxin mimic. J Am Chem Soc (2005) 1.16

Directing noble metal ion chemistry within a designed ferritin protein. Biochemistry (2008) 1.12

Comparison of bone marrow stromal cells derived from stroke and normal rats for stroke treatment. Stroke (2010) 1.12

A focused antibody library for selecting scFvs expressed at high levels in the cytoplasm. BMC Biotechnol (2007) 1.12

Simvastatin enhances bone marrow stromal cell differentiation into endothelial cells via notch signaling pathway. Am J Physiol Cell Physiol (2008) 1.10

An induced fit mechanism regulates p53 DNA binding kinetics to confer sequence specificity. EMBO J (2011) 1.10

Novel molecular targets of dezocine and their clinical implications. Anesthesiology (2014) 1.08

Inhalational anesthetic-binding proteins in rat neuronal membranes. J Biol Chem (2004) 1.08

Azi-isoflurane, a Photolabel Analog of the Commonly Used Inhaled General Anesthetic Isoflurane. ACS Chem Neurosci (2009) 1.08

Structural coupling between FKBP12 and buried water. Proteins (2009) 1.07

Adverse effects of bone marrow stromal cell treatment of stroke in diabetic rats. Stroke (2011) 1.06

Limitations of yeast surface display in engineering proteins of high thermostability. Protein Eng Des Sel (2006) 1.06

Increasing Ang1/Tie2 expression by simvastatin treatment induces vascular stabilization and neuroblast migration after stroke. J Cell Mol Med (2008) 1.05

eNOS mediates TO90317 treatment-induced angiogenesis and functional outcome after stroke in mice. Stroke (2009) 1.03

Using alpha-helical coiled-coils to design nanostructured metalloporphyrin arrays. J Am Chem Soc (2008) 1.02

Binding site and affinity prediction of general anesthetics to protein targets using docking. Anesth Analg (2012) 1.01

Computational protein design: structure, function and combinatorial diversity. Curr Opin Chem Biol (2007) 1.01

Identification of the active form of endothelial lipase, a homodimer in a head-to-tail conformation. J Biol Chem (2009) 1.00

Simvastatin increases notch signaling activity and promotes arteriogenesis after stroke. Stroke (2008) 1.00

Advances in computational protein design. Curr Opin Struct Biol (2004) 0.99

Computational design and elaboration of a de novo heterotetrameric alpha-helical protein that selectively binds an emissive abiological (porphinato)zinc chromophore. J Am Chem Soc (2010) 0.99

Treatment of stroke with a synthetic liver X receptor agonist, TO901317, promotes synaptic plasticity and axonal regeneration in mice. J Cereb Blood Flow Metab (2009) 0.97

Niaspan enhances vascular remodeling after stroke in type 1 diabetic rats. Exp Neurol (2011) 0.97

Nitric oxide regulates Angiopoietin1/Tie2 expression after stroke. Neurosci Lett (2006) 0.96

D-galactose injured neurogenesis in the hippocampus of adult mice. Neurol Res (2005) 0.96

Computational design of membrane proteins. Structure (2012) 0.95

Isoflurane binds and stabilizes a closed conformation of the leukocyte function-associated antigen-1. FASEB J (2012) 0.94

Neuroprotective effect of human placenta-derived cell treatment of stroke in rats. Cell Transplant (2013) 0.94

Salvinorin A produces cerebrovasodilation through activation of nitric oxide synthase, κ receptor, and adenosine triphosphate-sensitive potassium channel. Anesthesiology (2011) 0.93

Photoactive analogues of the haloether anesthetics provide high-resolution features from low-affinity interactions. ACS Chem Biol (2006) 0.93

NMR structure and dynamics of a designed water-soluble transmembrane domain of nicotinic acetylcholine receptor. Biochim Biophys Acta (2011) 0.93

A high-throughput approach for identification of novel general anesthetics. PLoS One (2009) 0.91

Combination treatment of experimental stroke with Niaspan and Simvastatin, reduces axonal damage and improves functional outcome. J Neurol Sci (2010) 0.91

Single-handed helical wrapping of single-walled carbon nanotubes by chiral, ionic, semiconducting polymers. J Am Chem Soc (2013) 0.90

Coimmunization with an optimized IL15 plasmid adjuvant enhances humoral immunity via stimulating B cells induced by genetically engineered DNA vaccines expressing consensus JEV and WNV E DIII. Vaccine (2009) 0.90

Design of functional ferritin-like proteins with hydrophobic cavities. J Am Chem Soc (2006) 0.90

Computational design and selections for an engineered, thermostable terpene synthase. Protein Sci (2011) 0.89

Comparative binding character of two general anaesthetics for sites on human serum albumin. Biochem J (2004) 0.89

Atorvastatin promotes presenilin-1 expression and Notch1 activity and increases neural progenitor cell proliferation after stroke. Stroke (2007) 0.89

Iliac graft vascularization for femoral head osteonecrosis. Clin Orthop Relat Res (2006) 0.89

Designing gene libraries from protein profiles for combinatorial protein experiments. Nucleic Acids Res (2002) 0.88

Niaspan treatment increases tumor necrosis factor-alpha-converting enzyme and promotes arteriogenesis after stroke. J Cereb Blood Flow Metab (2009) 0.87

Halothane binding proteome in human brain cortex. J Proteome Res (2007) 0.87

Effects of Olig2-overexpressing neural stem cells and myelin basic protein-activated T cells on recovery from spinal cord injury. Neurotherapeutics (2012) 0.86

D-galactose toxicity in mice is associated with mitochondrial dysfunction: protecting effects of mitochondrial nutrient R-alpha-lipoic acid. Biogerontology (2007) 0.86

Reward processing in adolescents with bipolar I disorder. J Am Acad Child Adolesc Psychiatry (2013) 0.86

Salvinorin A administration after global cerebral hypoxia/ischemia preserves cerebrovascular autoregulation via kappa opioid receptor in piglets. PLoS One (2012) 0.86

Scalable production of highly sensitive nanosensors based on graphene functionalized with a designed G protein-coupled receptor. Nano Lett (2014) 0.85

Highly tunable photoluminescent properties of amphiphilic conjugated block copolymers. J Am Chem Soc (2010) 0.85

Characterization of the cofactor-induced folding mechanism of a zinc-binding peptide using computationally designed mutants. J Mol Biol (2009) 0.85

Cell-cell interaction promotes rat marrow stromal cell differentiation into endothelial cell via activation of TACE/TNF-alpha signaling. Cell Transplant (2009) 0.84

Engineering complementary hydrophobic interactions to control β-hairpin peptide self-assembly, network branching, and hydrogel properties. Biomacromolecules (2014) 0.84

Molecular Dynamics Simulation of WSK-3, a Computationally Designed, Water-Soluble Variant of the Integral Membrane Protein KcsA. Biophys J (2005) 0.83

Highly Stable, Dual-Gated MoS2 Transistors Encapsulated by Hexagonal Boron Nitride with Gate-Controllable Contact, Resistance, and Threshold Voltage. ACS Nano (2015) 0.83

Ferritin couples iron and fatty acid metabolism. FASEB J (2012) 0.83

Upper extremity deep vein thrombosis in a patient treated for malignant hyperthermia. J Clin Anesth (2013) 0.82

Salvinorin A pretreatment preserves cerebrovascular autoregulation after brain hypoxic/ischemic injury via extracellular signal-regulated kinase/mitogen-activated protein kinase in piglets. Anesth Analg (2011) 0.82

Characterization of a computationally designed water-soluble human μ-opioid receptor variant using available structural information. Anesthesiology (2014) 0.82

Computational de novo design and characterization of a protein that selectively binds a highly hyperpolarizable abiological chromophore. J Am Chem Soc (2013) 0.82

Facile preparation of nitrogen-doped few-layer graphene via supercritical reaction. ACS Appl Mater Interfaces (2011) 0.82

Inhaled anesthetics elicit region-specific changes in protein expression in mammalian brain. Proteomics (2008) 0.82

GM1 ganglioside prevented the decline of hippocampal neurogenesis associated with D-galactose. Neuroreport (2005) 0.81

Neurological deficits in mice with profound biotinidase deficiency are associated with demylination and axonal degeneration. Neurobiol Dis (2012) 0.81

Dynamics of Elective Case Cancellation for Inpatient and Outpatient in an Academic Center. J Anesth Clin Res (2013) 0.81

Niaspan treatment improves neurological functional recovery in experimental autoimmune encephalomyelitis mice. Neurobiol Dis (2008) 0.81

Ligand and coactivator recruitment preferences of peroxisome proliferator activated receptor alpha. J Steroid Biochem Mol Biol (2002) 0.81

Protective effect of tetramethylpyrazine on learning and memory function in D-galactose-lesioned mice. Chin Med Sci J (2004) 0.81

Simulation of pH-dependent edge strand rearrangement in human beta-2 microglobulin. Protein Sci (2005) 0.80

Probabilistic approach to the design of symmetric protein quaternary structures. Protein Eng (2003) 0.80